Another anti-hypertrophic miR, miR-132, controls cardiac hypertrophy in a novel porcine model of pressure-overload-induced heart failure via PPARGC1A/NFE2 signaling by targeting SIRT1 (104). Here, NFE2 is linked to cardiac hypertrophy.